Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides.

Domingo-Calap P, Schubert B, Joly M, Solis M, Untrau M, Carapito R, Georgel P, Caillard S, Fafi-Kremer S, Paul N, Kohlbacher O, González-Candelas F, Bahram S.

PLoS Pathog. 2018 Oct 18;14(10):e1007368. doi: 10.1371/journal.ppat.1007368. eCollection 2018 Oct.

2.

HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Ramaswami B, Popescu I, Macedo C, Metes D, Bueno M, Zeevi A, Shapiro R, Viscidi R, Randhawa PS.

Hum Immunol. 2009 Sep;70(9):722-8. doi: 10.1016/j.humimm.2009.05.003. Epub 2009 May 14.

3.

BK Polyomavirus Genomic Integration and Large T Antigen Expression: Evolving Paradigms in Human Oncogenesis.

Kenan DJ, Mieczkowski PA, Latulippe E, Côté I, Singh HK, Nickeleit V.

Am J Transplant. 2017 Jun;17(6):1674-1680. doi: 10.1111/ajt.14191. Epub 2017 Feb 21.

4.

The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome.

Kenan DJ, Mieczkowski PA, Burger-Calderon R, Singh HK, Nickeleit V.

J Pathol. 2015 Nov;237(3):379-89. doi: 10.1002/path.4584. Epub 2015 Aug 19.

5.

Association of BK Virus Infection with CXCL11 Gene Expression and Protein Levels in Kidney Transplant Patients.

Kariminik A, Yaghobi R, Dabiri S.

Exp Clin Transplant. 2018 Feb;16(1):50-54. doi: 10.6002/ect.2015.0361. Epub 2016 Oct 14.

6.

Evaluation of polyomavirus BK cellular immune response by an ELISpot assay and relation to viral replication in kidney transplant recipients.

Costa C, Mantovani S, Piceghello A, Di Nauta A, Sinesi F, Sidoti F, Messina M, Cavallo R.

New Microbiol. 2014 Apr;37(2):219-23. Epub 2014 Apr 1.

7.

The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.

Brochot E, Desoutter J, Presne C, De Araujo I, Flahaut G, Castelain S, Westeel PF, Choukroun G, Guillaume N.

Transpl Int. 2016 Nov;29(11):1168-1175. doi: 10.1111/tri.12820. Epub 2016 Sep 12.

8.

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.

Peretti A, Geoghegan EM, Pastrana DV, Smola S, Feld P, Sauter M, Lohse S, Ramesh M, Lim ES, Wang D, Borgogna C, FitzGerald PC, Bliskovsky V, Starrett GJ, Law EK, Harris RS, Killian JK, Zhu J, Pineda M, Meltzer PS, Boldorini R, Gariglio M, Buck CB.

Cell Host Microbe. 2018 May 9;23(5):628-635.e7. doi: 10.1016/j.chom.2018.04.005.

PMID:
29746834
9.

Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity.

Chen Y, Sharp PM, Fowkes M, Kocher O, Joseph JT, Koralnik IJ.

J Gen Virol. 2004 Sep;85(Pt 9):2651-63.

PMID:
15302959
10.

Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.

Zeng G, Huang Y, Huang Y, Lyu Z, Lesniak D, Randhawa P.

Am J Transplant. 2016 Nov;16(11):3131-3138. doi: 10.1111/ajt.13911. Epub 2016 Jul 15.

11.

BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R.

Clin Microbiol Rev. 2017 Apr;30(2):503-528. doi: 10.1128/CMR.00074-16. Review.

12.

Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications.

Yogo Y, Sugimoto C, Zhong S, Homma Y.

Rev Med Virol. 2009 Jul;19(4):185-99. doi: 10.1002/rmv.613. Review.

PMID:
19530118
13.

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.

Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, Woodle ES, Khalili K, Koralnik IJ.

J Virol. 2006 Apr;80(7):3495-505.

14.

Noncoding Control Region Pattern of BK polyomavirus in Kidney Transplant Patients With Nephropathy.

Emami A, Yaghobi R, Moattari A, Baseri Salehi M, Roozbeh J.

Exp Clin Transplant. 2017 Apr;15(2):150-156. doi: 10.6002/ect.2014.0230. Epub 2015 Oct 30.

15.

Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy.

Lonergan RM, Carr MJ, De Gascun CF, Costelloe LF, Waters A, Coughlan S, Duggan M, Doyle K, Jordan S, Hutchinson MW, Hall WW, Tubridy NJ.

J Neurovirol. 2009 Sep;15(5-6):351-9. doi: 10.3109/13550280903131923.

PMID:
19670070
16.

HLA susceptibility to BKV infection.

Awadallah Y, Duquesnoy R, Randhawa P, Shapiro R.

Am J Transplant. 2006 Mar;6(3):640; author reply 641. No abstract available.

17.

An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination.

Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R, Mandelboim O.

Cell Host Microbe. 2011 Feb 17;9(2):93-102. doi: 10.1016/j.chom.2011.01.008.

18.
19.

Molecular networks involved in the immune control of BK polyomavirus.

Girmanova E, Brabcova I, Klema J, Hribova P, Wohlfartova M, Skibova J, Viklicky O.

Clin Dev Immunol. 2012;2012:972102. doi: 10.1155/2012/972102. Epub 2012 Dec 5.

20.

HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity.

Hammer MH, Brestrich G, Andree H, Engelmann E, Rosenberger C, Tillmann H, Zwinger S, Babel N, Nickel P, Volk HD, Reinke P.

Am J Transplant. 2006 Mar;6(3):625-31.

Supplemental Content

Support Center